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Shigella flexneri is a Gram negative facultative anaerobe that infects millions 
world-wide each year.  The route for infection of a host is through the intestinal and 
rectal epithelium layers, but it also can survive in the environment.  Different genes have 
been found to be up regulated depending upon its presence in the intracellular or 
extracellular environment, as shown in previous work in the lab.  This thesis seeks to 
examine the role these upregulated genes, bioA and lysA, play in the intracellular activity 
of S. flexneri.  Knock-out mutations in the bioA and lysA genes were created using P1 
transduction.  To test the effects of these mutations on S. flexneri, plaque, invasion, and 
attachment assays were performed.  It was found that the bioA mutation resulted in fewer 
plaques being formed, while the lysA mutation resulted in slower forming and 
incompletely lysed plaques being formed.   
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Introduction and Background 
Shigella flexneri is a Gram negative facultative anaerobe that can invade and 
replicate inside the cytosol of human colonic epithelial cells (Jennison 2003).  S. flexneri 
causes about 165 million cases of shigellosis or bacterial dysentery annually, resulting in 
over a million deaths world-wide (Jennison 2003). S. flexneri can survive in both the 
environment and the human gut.  Differences between its physiology in the outside 
environment versus inside the host has been an area of interest.   
Pathogenesis of S. flexneri 
S. flexneri is passed between hosts via the fecal-oral route.  Infection is usually 
acquired through contaminated water supplies or through hand-to-hand contact.  The 
pathogenesis of S. flexneri is linked to the damage it causes to the host by its ability to 
invade and replicate inside colonic and rectal epithelial cells (Jennison 2003).  This 
invasion causes inflammation of the tissues and lysis of the epithelial cells lining the 
colon and rectum leading to ulceration and abscess.  The damage done to the colorectal 
epithelial cells leads to the symptoms of shigellosis, including the passage of bloody 
mucoid stools.  Figure 1 diagrams the route that S. flexneri takes in the initial invasion of 
an epithelial cell.   
S. flexneri that are ingested by the host are able to survive the acidic conditions of 
the stomach by regulating the expression of certain genes based on pH.    An expression 
profiling study was done on S. flexneri in acidic conditions and it was found that among 
the acid resistance genes are genes that regulate energy metabolism, the RpoS-dependent  
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Figure 1:  Schematic diagram of the process of infection of epithelial cells with S. flexneri 
(figure from N. Davies).   
 
S. flexneri invades epithelial cells via the basolateral membrane.  In order to reach the 
basolateral membrane S. flexneri can pass across the epithelial cell layer in three ways:  
through membranous cells in the monolayer, by maneuvering the tight junctions between 
epithelial cells, or by through the junctions made by polymorphonuclear neutrophil cells 
as they are moving to the site of inflammation.  S. flexneri, shown as red bars, are taken 
up by the membranous epithelial cells, shown in blue.  The bacteria are then transcytosed 
to the antigen presenting cells on the basolateral side.  The bacteria are phagocytozed by 
macrophages present in the cavity provided by the membranous epithelial cells, shown in 
pink.  When S. flexneri are taken up by the macrophages, they are able to induce 
apoptosis of the macrophage and escape.  They can then enter the epithelial cells via the 
basal lateral membrane and move across the cell layer intracellularly through pseudo-







acid-resistance genes, and several stress response genes.  It was also found that many 
virulence associated genes were down-regulated, consistent with S. flexneri infecting the 
lower gut (Cheng, et al. 2007).    
 Infection by S. flexneri requires an infectious dose as low as 100 cells partly due 
to the up-regulation of acid resistance genes when it reaches the host stomach (Jennison 
2003).  Those gene products allow S. flexneri to survive the acidic conditions of the host 
stomach in order to reach the intestinal epithelial cells.  The host immune response 
against infection by S. flexneri is mediated primarily by inflammation.  The inflammation 
response, however, can be used to the advantage of the pathogen during infection in order 
to spread to additional epithelial cells.     
S. flexneri Invasion and Intracellular Growth 
The intracellular lifecycle of S. flexneri has been studied and some mechanisms of 
infection and replication have been elucidated.  S. flexneri is able to be taken up by the 
epithelial cells through clathrin-dependent endocytosis.  S. flexneri induces endocytosis 
not though binding to a specific cellular receptor, but by use of a type III secretion 
system.  The type III secretion system allows the bacteria to inject its effector proteins 
directly into the epithelial cell cytosol.  The effector protein IpaC from S. flexneri 
interacts with the host actin cytoskeleton by inducing actin polymerization either directly 
or in conjunction with small GTPases. The result of this polymerization is the formation 
of membrane extensions that are loosely attached to the bacteria.  IpaC is also able to 
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activate the host Abl kinase required to produce filopodial-like formation of the epithelial 
cell membrane around the bacteria by interaction of  IpaC with Cdc24 (Veiga 2006).     
S. flexneri then gains entry to the cytoplasm of the epithelial cell by escaping from 
the vacuole it formed during internalization.  In order to break out of the vacuoles, S. 
flexneri disrupts the vacuole membrane by use of the type III secretion system in order to 
escape into the cytosol.  The IpaB effector protein assembles with IpaC to form a pore 
complex that binds cholesterol.  It is thought that this complex is able to bind the 
vacuolar membrane and disrupt the membrane through insertion, resulting in the bacterial 
escape into the cytosol (Ray 2008). The cycle of S. flexneri invading and spreading 
among epithelial cells is shown in Figures 2.   
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Figure 2: S. flexneri invasion and infection cycle.   
 
A.  The cycle of S. flexneri invasion of epithelial cells.  S. flexneri, shown as red bars in 
the figure, enters the host by using their type III secretion system to induce uptake. They 
then secrete IpaB and IpaC shown as green circles which together form a pore complex, 
shown as green circles, that allows the disruption of the vacuole membrane. Once free in 
the cytosol, the S. flexneri replicates and utilizes host actin, shown as orange lines, to 
become motile.  (Adapted from Ray 2009) 
 
B.  The cycle of S. flexneri spread to neighboring cells.  Intracellular spread occurs when 
the S. flexneri induces the formation of a secondary vacuole. S. flexneri secretes the Ipa 
protein to form the pore complex and disrupt the vacuole membrane.  The bacteria can 










Once the S. flexneri is free in the cytosol, it can commence replication.  In order to 
examine what allows some bacterial species to replicate in the cytosol while others 
cannot,  Escherichia coli engineered to express an invasin protein from Yersinia 
pseudotuberculosis and  to coat itself with listeriolysin O, a protein required by Listeria 
species to escape the vacuole.  This allowed the normally extracellular bacteria, E. coli, to 
replicate in the cytosol (Ray, et al. 2009).  This phenomenon has also been found in 
Bacillus subtilis engineered to express listeriolysin O (Monack and Theriot, 2001).  
However, in another study, it was found that when various bacteria were microinjected 
into epithelial cells, only those previously known to live and replicate in the cytosol were 
able to do so, while the other species including: Yersinia enterocolitica, E. coli strain 536, 
and B. subtilis; failed to replicate (Goetz, et al., 2001).  To explain this paradox, it has 
been proposed that necessary changes take place while the bacteria are inside the vacuole 
in order to allow for cytosolic growth (Ray 2008).   
 While S. flexneri is non-motile in the environment, it polymerizes actin to gain 
motility within the cytosol.  This actin-based motility can help facilitate the spread of the 
bacteria to neighboring cells (Ray 2008).  The effector protein IcsA binds to tubulin 
oligomers to inhibit microtubule formation, while indirectly promoting polymerization of 
actin (Viega 2006).  Actin polymerization occurs at one pole of the bacterium and 
provides it with propulsive force needed to move through the cytosol.  Critical for actin-
based motility are the bacterial outer membrane protein, VirG, and the host neural 
Wiskott-Aldrich syndrome protein, N-WASP.  VirG and Cdc24 bind and activate N-
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WASP, which in turn recruits the actin-related proteins 2 and 3, known as Arp2/3 
(Yoshida 2006).   
 Direction of the Research 
Previous work done in our lab has identified several potentially novel 
requirements for the pathogenesis of S. flexneri (Runyen-Janecky 2002).  Green 
fluorescent protein (gfp) promoter fusions were created in S. flexneri and activated 
through differential fluorescence induction.  The gfp is promoter-less so activation of gfp 
indicates that the promoter it was fused to was activated under the growth conditions.  
The cells were grown either in L broth or in Henle cells and fluorescence activated sell 
sorting was used to sort cells based on fluorescence.  Of the genes that were found to be 
up-regulated during intracellular growth, three are involved in metabolic processes: uhpT, 
bioA, and lysA, which encode a sugar phosphate transporter, an enzyme involved in biotin 
synthesis, and an enzyme involved in lysine synthesis, respectively.  A uhpT disruption 
mutant was unable to utilize glucose-6-phosphate as its sole carbon source; however, it 
was able to exhibit normal plaque formation on epithelial cell monolayers.  bioA was 
found to be up-regulated 5 fold, while lysA was found to be up-regulated 3 fold (Runyen-
Janecky, 2002).   
This upregulation in the intracellular environment was also found in a microarray 
study that examined S. flexneri growing in Hela cells.  The microarray data identified 
bioA and lysA among genes upregulated intracellularly (Lucchini, 2005).   
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My research seeks to examine the necessity of bioA and lysA in S. flexneri 
pathogenesis and intracellular survival by knocking out the genes of interest and 
examining their virulence in Hela cells.  
Biotin Synthesis and Importance 
Biotin is a coenzyme in various carboxylase reactions, for example the pyruvate 
to oxaloacetate reaction in the gluconeogenesis pathway.  The chemical structure of the 
biotin molecule is shown in Figure 3A.  The bioA gene is a part of the biotin operon 
which encodes enzymes that catalyze the reactions responsible for producing biotin.  The 
gene product of bioA is diaminoperalgonic aminotransferase (DAPA AT).   Figures 3B 
and 3C diagram the pathway and genes involved in the production of biotin by S. flexneri 





Figure 3: Biotin Biosynthesis: 
A. Chemical structure of biotin.  A carboxyl group is bound to a hydrocarbon chain 
bound to the sulfur containing ring.   
B. Synthesis pathway of biotin. The bioA gene product, diaminoperalgonic 
aminotransferase, catalyses the conversion of 7-KAP to 7-DAPA.   
C. Organization of biotin synthesis related genes. The genes involved in biotin synthesis 

















In work done on Mycobacterium tuberculosis, also an intracellular pathogen of 
humans, a suicide substrate for DAPA AT was able to bind and stop the activity of the 
enzyme.  When DAPA AT was inhibited, growth was completely inhibited on biotin-free 
Luria Bertani agar medium.  This process was found to be reversible by adding biotin to 
the medium (Mann 2006).  Since biotin is essential for the M. tuberculosis auxotroph to 
grow, it may follow that biotin is vital for the growth of S. flexneri as well.  The biotin 
biosynthetic pathway has the potential to be a target for the development of antibiotics 
because humans do not synthesize biotin.  An inhibitor of DAPA AT could be useful 
since this enzyme is not produced or required by humans.    
 Researchers in Japan performed a genetic analysis of a Bacillus subtilis strain that 
was unable to synthesize its own biotin.  Bacillus subtilis Natto OK2  is used 
commercially in the fermentation of soybeans and required biotin for growth.  The 
genetic defects in this strain are in the bioW and bioF genes and result in biotin 
auxotrophy.   The strain does not exhibit wild type growth in minimal medium 
unsuplemented with biotin.  The growth curve exhibits a death phase after 4 hours of 
growth followed by a second growth phase after 6 hours.  The strain reaches stationary 
phase at an OD650 of 0.1 while the wild type reaches stationary phase at an OD650 of 1.0 
(Sasaki, 2004).    
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Lysine Synthesis and Importance 
Lysine synthesis has been recently examined as a possible target for new 
antibiotic agents.  Not only is lysine a component of proteins, but the last precursor in its 
biosynthetic pathway, meso-diaminopimelate, is also a component of the peptidoglycan 
cell wall.  The lysine chemical structure and biosynthetic pathway is shown in Figure 4.  
An antibiotic that targeted lysine synthesis would not be expected to cause adverse 
reactions in humans because mammals do not synthesize lysine (Hutton 2003).  The lysA 
gene encodes for diaminopimelate decarboxylase (DD).  DD catalyzes the last step in the 
lysine biosynthetic pathway, and the product of that reaction is lysine (Patte 1996).   
 A gene involved in lysine synthesis in the fungus Aspergillus fumigatus has been 
shown to influence virulence in a mouse model of infection.  LysF was deleted in A. 
fumigates, and the end result of the mutation was to create an A. fumigates lysine 
auxotroph.  The resulting auxotroph was avirulent at low doses (Liebman, et al, 2004).  
This suggests a demand for the biosynthesis of lysine for virulence.     
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Figure 4: Lysine Biosynthesis 
A.  Lysine Chemical Structure.  Lysine is a positively charged amino acid.   
 
B.    Lysine Biosynthetic Pathway.  The substrates and genes involved in lysine synthesis.  
The lysA gene product catalyses the last reaction in the pathway, the conversion of meso-
diaminopimelate to lysine by diaminopimelate decarboxylase.   
  
C.  Organization of lysine synthesis related genes. lysA is located between the galR gene 
and the lysR gene.  The remainder of the lysine biosynthesis genes are located around the 
genome.  
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Materials and Methods 
Bacterial Strains 
 The bacterial strains used in this research are listed in Table 1.  S. flexneri strain 
2457T serotype 2a was used as the wild type strain.  Cloning was performed using CaCl2 
competent E. coli DH5α.  Keio strains JW0757 and JW2806 were obtained by request 
from the Keio Collection (Baba, et al., 2006).   
Primer List  
The primers utilized in this research are listed in Table 2.  Unless otherwise noted, 
all primers were designed by the author using Clone Manager Professional Software 
Suite (Sci Ed Central).   Primers were ordered from Invitrogen and were resuspended at 
100µM.   
Polymerase Chain Reaction and Ligations 
 PCR and ligations were performed according to Ausubel et al, 2003.  Both 
reactions were run in an Applied Biosystems GeneAmp thermo cycler.  PCRs were 
performed using Taq DNA polumerase provided by New England Biolabs (Ipswich, MA) 
or Pfx DNA polymerase provided by Invitrogen (Carlsbad, CA).   
The standard PCR mix contained 2 units of polymerase enzyme, 800µM dNTP 
mixture, 2µM oligonucleotide primers, buffer solution, and either template DNA or a 
colony picked from a plate.  For reactions using Pfx, MgSO4 was added at a 
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concentration of 1 mM.  The standard reaction conditions for Taq reactions were 30 
cycles of 30 seconds of 94°C for denaturation, 30 seconds of annealing, 1 minute at 72°C 
for each 1000bp for elongation, and 10 minutes at 72° for a final elongation.  The 
standard reaction conditions for Pfx reaction conditions were 30 cycles of 15 seconds at 
94°C for denaturation, 30 seconds of annealing, 1 minute at 68°C for each 1000bp for 
elongation, and 5 mutes at 68°C for a final elongation.  PCR products were 
electrophoresed on 0.75% agarose gels.    
 Ligations were carried out using T4 DNA ligase and its corresponding buffer.  
Reactions were allowed to ligate at 16°C overnight in a thermocycler.    
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Table 1:  Bacterial strains used in this research: 
Strain Characteristics Reference 
E. coli Strains:     
MG1655 K-12 (Blattner et al., 1997)  
W3110 F
-
 IN(rrnD-rrnE)1 (Henderson et al., 1993) 
DH5α 
endA1 hsdR17 supE44 thi-1 recA1 
gyrA96 relA1 ∆(lacZYA-argF)U169 
deoR [∆80dlac ∆(lacZ)M15] 
 (Hanahan et al. , 1983) 
 
JW0757  Keio strain, bioA-, KanR  (Baba et al.  , 2006) 
JW2806  Keio strain, lysA-, KanR  (Baba et al., 2006) 
      
S. flexneri  Strains:     
2457T Wild type S. flexneri serotype 2a  (Wei et al., 2003) 
∆bioA 2457T bioA::Kan This work 
∆lysA 2457T lysA::Kan This work 
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Table 2:  List of primers used in this research. 
Primer Name Sequence Tm (C°) 
lysAfor 5’TTCCCGTAGGCTGATGGAGTG3’  56 
lysArev 5’TGGCGAACCAGACGAAAGC3’  56 
lysA2for 5’TGGAGCGTTTCAGTGAGTC3’ 55 
lysA2rev 5’AAGGTCATACCCGCATTGG3’ 55 
bioAfor 5’GCGCCTGAGATTCACTCAAC3’ 55  
bioArev 5’TACCAGACCAGAGCCAAACC3’ 55  
PD4for* 5’GTCCGGTGCCCTGAATGAAC3’ 56 
PD4rev* 5’GGAGCGGCGATACCGTAAAG3’  56 
 




 Plasmid purification was done using a GenElute Plasmid Miniprep kit from 
Sigma-Aldrich (St. Louis, MO).  The kit was used according to the manufacturer’s 
directions.  The isolated DNA in the eluate was stored at -20°C.   
Restriction Enzyme Digests 
 Restriction enzyme digestions were purchased from New England Biolabs 
(Ipswich, MA).  The digestions were incubated in water baths at the manufacturer’s 
recommended temperature for at least 4 hours.  Restriction enzyme buffers and BSA 
were also provided by New England Biolabs and were included as recommended for each 
enzyme.  The digested fragments were subjected to gel electrophoresis and the band was 
excised and extracted using a Sigma GelElute Gel Extraction Kit.  The protocol provided 
by Sigma was utilized and the fragments were eluted into 50µl of the provided elution 
solution.   
Tissue Culture Maintenance 
 The Henle cells were cultured using modified eagle medium (MEM) purchased 
from Invitrogen.  To prepare the MEM complete medium, 10% fetal bovine serum, 10% 
tryptose phosphate broth, 2mM glutamine, and non-essential amino acids were added to 
the stock MEM.  The non-essential amino acids (Sigma Aldrich) included L-alanine at 89 
µg/L, L-asparagine·H2O at 150µg/L, L-aspartic acid at 133µg/L, L-glutamic acid at 
147µg/L, glycine at 75µg/L, L-proline at 115µg/L, and L-serine at 105µg/L.  The Henle 
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cells were split using a trypsin working solution of 80/20 mixture of versine and trypsin 
stock solution.  The versine was made by adding 1.5 ml 0.5% phenol red to 500 ml PBS 
and filter sterilizing the solution.  The PBS-D was made by adding 50 ml 10X PBS and 5 
ml 0.1m EDTA to 450 ml sterile water.  The trypsin stock solution was made by adding 
0.25 ml trypsin, 0.1g Na2EDTA, and 0.3 ml 0.5% phenol red to 100 ml PBS.   
P1 Transduction 
P1 phage transduction was utilized to introduce knock-out mutations in the genes 
of interest.  The phage stock and protocol were provided by Dr. Ian Molineaux’s 
laboratory.  The stock phage was amplified to a titer of 4.16X10
9
 pfu/ml by growing the 
phage in E. coli MG1655 and then harvesting the phage lysate.  The lystate was stored at 
4°C.  The phage lysate was titered by plating the lysate with E. coli MG1655.  Keio 
collection strains JW0757 and JW2806 were used as the donors of the target DNA 
region.  Strain JW0757 has the bioA gene replaced with a kanamycin cassette while strain 
JW2806 has the lysA gene replaced with the kanamycin cassette.   
Growth Curve Protocols 
Growth curves were examined in both LB medium, recipe in Appendix A, and in 
minimal medium both with and without supplementation with lysine or biotin.  The 
minimal medium used was T medium (Appendix A).  Biotin was supplemented at a final 
concentration of 100µM and lysine was supplemented at 300µM, recommended for E. 
coli auxotrophs (Davis, et al.).   
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  The strains to be examined with the growth curve were grown overnight with 
shaking in test tubes at 37°C.  In the morning the optical density (OD) was read using a 
Beckman DU 640 Spectrophotometer.  The overnight cultures were then diluted to an 
OD650 of 0.02 in the indicated medium.  The samples were then placed into the 37°C 
incubator shaker for the duration of the growth.  The OD was read every hour for a 12 
hour period and then once more at 24 hours.  To increase the accuracy of the OD 
readings, once the undiluted OD650 of the culture reached 0.5, the remaining time point 
samples were diluted 1:10 in cuvettes with either T medium or L broth, depending upon 
the growth curve medium.   
Plaque Assay Protocol 
Plaque assays were performed using confluent Henle cell monolayers.  The 
following protocols were adapted from Oaks, et al. (1985).  Henle cells were grown to 
confluent monolayers in 6 well plates (Corning Incorporated Costar 3506).  The 
monolayers were washed with PBS and fresh medium was added prior to infection.  The 
S. flexneri strains were streaked out on TSBA containing 0.01% Congo red, 50mM 
NaCitrate, 100µM biotin, 300µM lysine, and 50µg/ml kanamycin (only for the kan
R
 
strains).  Colonies that bound Congo red were used to inoculate L broth and grown in a 
37°C shaking incubator until they reached mid log phase.  The cell concentration was 
estimated by multiplying the OD650 at mid log by 8x10
8
 cells/ml.  The samples were then 




 cells/ml.   
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Henle cell monolayers in 6 well plates with fresh MEM medium were inoculated 
with the dilutions of bacteria.  The plates were centrifuged in an IEC Centra GP8 
centrifuge at 1000 RPM at room temperature for 10 minutes and placed into a 37°C/5% 
CO2 incubator for 45 minutes. After incubation the medium was replaced with fresh 
medium containing 10 µg/ml gentamycin.  The mutants were assayed both with and 
without biotin or lysine supplementation.  When added, the final concentration of lysine 
was 300µM and biotin was 100µM.   
The plates were placed back into the 37°C/5% CO2 incubator to allow for plaque 
formation.  The medium was changed every 24 hours.  After 48 or 72 hours, the medium 
was removed from the well and the remaining monolayer was washed twice with 1 ml of 
PBS.  Each monolayer was then stained with Wright/Geimsa stain for 60 seconds, and the 
stain was removed by aspiration.  The wells were rinsed with water and the number and 
size of visible plaques were recorded.   
Attachment Assay Protocols 
Attachment assays examine the proportion of the auxotrophs attaching to the 
surface of epithelial cells in comparison to wild type S. flexneri.  These protocols were 
adapted from Hale and Formal, 1981.  The attachment assays require Henle cell 
monolayers that are subconfluent, about 50% confluency.  Cultures of S. flexneri were 
grown to mid-log while shaking at 37°C.  The cultures were pelleted and then 
resuspended at a concentration of 2x10
9
 cells/ml.  The resuspension volume was 
calculated by multiplying the OD650 by 8x10
8
 cells/ml.   
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The Henle cell sub confluent monolayers were infected with approximately 2x10
8
 
cells of resuspended bacteria.  The plates were centrifuged at 1,000 RPM for 5 minutes 
and placed in the 37°C/5% CO2 for 15 minutes.  The plates were removed from the 
incubator and the media was removed from the wells.  The wells were washed with PBS, 
and fresh medium containing 10 µg/ml gentamycin was added to the wells.  The plates 
were placed back into the 37°C/5%CO2 incubator for 1.5 hours.  The plates were 
removed from the incubator and the medium was aspirated.  The wells were washed 
twice with 1 ml of PBS, and the monolayers were stained with Wright/Giemsa.     
Invasion Assay Protocols 
Invasion assays were then set up to examine the rate that the auxotrophs invaded 
the epithelial cells in comparison to wild type S. flexneri. Invasion assays were carried 
out with protocols similar to the attachment assays and were adapted from Hale and 
Formal, 1981.  The difference in the protocols was the incubation and centrifugation 
times.  The plates were centrifuged at 1,000 RPM for 10 minutes and then placed in the 
37°C/5% CO2 incubator for 30 minutes.   
Complementation Protocol 
After assays were completed, a plasmid carrying the lysA gene was constructed to 
complement the lysA auxotroph using plasmid pWKS30.  pWKS30 was modified from 
the pSC101 plasmid (Wang and Kushner, 1991).  It contains the lacZα gene with a 
multiple cloning site, and it carries ampicillin resistance.  Transformants can be selected 
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on ampicillin and screened on X-gal and IPTG to identify those in which the lacZ gene 
has been disrupted.  The vector map of pWKS30 is shown in Figure 5.   
 The plasmid was digested with SmaI and ligated to the HincII/HpaI-digested lysA 
fragment.  T4 DNA ligase was used with its corresponding T4 DNA liagase buffer.  The 
ligation mix was placed in a thermocycler at 16°C overnight.  The ligation mix was then 
added to E. coli DH5α CaCl2 competent cells (Ausubel et al. 2003).  The transformed 
cells were plated on 25 µl/ml ampicillin + IPTG + X-gal L agar in order to allow for 
blue/white screening.  PCR was performed using primers for2 and rev2.  The products 
were sequenced and BLAST analyses confirmed the presence of the lysA gene.   
Transformation of S. flexneri with pWKS30 
 The G Buffer method of transformation was used to produce a competent S. 
flexneri ∆lysA mutant and transform it through electroporation with the pWKS30 plasmid 
carrying lysA (Occhino et al. 1998).  G Buffer is a solution consisting of 137mM sucrose 
and 1mM HEPES (pH 8).  Electroporation was carried out at 200Ω, 25 mF, and 24V.  
The transformation mix was plated on TSBA containing 0.01% Congo red, 50mM 
NaCitrate, and 25µg/ml ampicillin. To confirm the presence of the plasmid carrying the 
lysA gene, plasmid purification and PCR screening using the for2 and rev2 primers was 
completed on eight transformants.  The lysA gene was found in the plasmids isolated 










Using transduction, a S. flexneri 2457T lysA deletion mutant was created.  Keio 
donor strains were used for transducing kanamycin resistance cassettes into the genes of 
interest in this project.  The Keio strains are a collection of Escherichia coli K-12 
BW25113 strains that have non-essential genes removed and replaced with a kanamycin 
resistance cassette flanked by flippase (FLP) recognition target sites (Baba 2006).  
Transducing the mutation from the Keio mutants allows the creation of in-frame, single 
gene knock-out mutants of the bioA and lysA genes and enables screening on selective 
medium containing kanamycin.   
The putative mutants were screened by PCR using primers specific for regions 
inside the kanamycin cassette and regions specific to the regions flanking the kanamycin 
cassette.  The primers used for screening the ∆lysA putative mutant were lysAfor and 
lysArev.  The primers used for screening ∆bioA putative mutants were bioAfor and 
bioArev.  The results of gel electrophoresis with these putative mutants are included in 
Figure 6.  The lanes with reactions using the internal kanamycin primers and the flanking 
gene primers show that the E. coli donors and the putative mutants contain the kanamycin 
cassette.  The lanes with reactions using just the primers for the flanking regions show the 
band size of the putative mutants is the same as the band size of the E. coli donor and not 
the S. flexneri wild type.  The primer set lysAfor and lysArev bind to sites upstream and 
downstream of the lysA gene.  The primer set bioAfor and bioArev bind to sites upstream 
and downstream of the bioA gene.  The size difference between the putative mutants and 
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the E. coli donor to the S. flexneri 2457T wild type is slight.  Primers PD4for and PD4rev 
bind to sites within the kanamycin cassette carried by the donor and inserted into the 
∆lysA and ∆bioA mutants.  PCRs that use the PD4 primers, in either the forward or 
reverse directions, should not have any binding when using 2457T as the template.   
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Figure 6:  PCR screening results of the ∆lysA and ∆bioA mutants. 
 
A:  The gel image of the PCR reactions run the ∆lysA putative mutants run on a 0.75% 
agarose gel.  Lanes labeled as “ladder” contain 5 µl of λ DNA digested with HindIII.   
 
B: The gel image of the PCR reactions run on the ∆bioA putative mutant run on a 0.75% 
agarose gel.  Lanes labeled as “ladder” contain 5 µl of λ DNA digested with HindIII.   
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B: ∆bioA putative mutants 
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Growth Curves 
Growth curves for the ∆lysA mutant have shown wild-type growth rates when 
grown in L broth (Figure 7A).  However, there is a transition into stationary phase at a 
lower OD650 when the mutant is grown in minimal medium, relative to the wild type in 
minimal medium.  When the mutant is supplemented with lysine at a concentration of 
100uM in minimal medium, the transition to stationary phase occurs at a higher OD650 
but still does not exhibit wild type behavior.  The growth curve was performed again with 
the lysine supplementation increased to 300µM, however, all four times it was repeated 
the ∆lysA grew at a rate faster than wild type S. flexneri.  For future work the growth 
curve can be performed using different minimal mediums.   
Growth curves were performed as a preliminary observation of the effects of the 
mutations.  If a growth defect was noted in the growth curves, such as a longer lag phase, 
the defect would need to be taken into account when the strains were grown for use in the 
virulence assays.  When the auxotrophs were growing in a rich medium, any growth 
defect would have raised concerned over whether a secondary mutation had occurred.  
Growth was examined in minimal medium to monitor effects of the auxotrophs growing 
without the compound they could not produce.  They were gown in the minimal medium 
with biotin or lysine supplemented to test whether or not wild type growth could be 
restored in minimal medium.  The results are shown in Figures 7 and 8.  Growth was 
more similar to wild type for both auxotrophic strains when they were supplemented.   
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Figure 7:  ∆lysA Growth Curves 
 
A:  The ∆lysA mutant grows similarly to wild type 2457T in L broth.  24 hour growth 
curve done in L broth. Time points were taken every hour for 12 hours and then again at 
24 hours. 
 
B:  The ∆lysA mutant grows better in minimal medium with lysine supplemented.  The 
strains were examined both without lysine and in the presence of lysine (100uM). Time 
points were taken every hour for 12 hours and then again at 24 hours.   
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A: L broth growth curve: 
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Transduction was also used to create a ∆bioA deletion mutant.  Growth in L broth 
for the deletion mutant is at the same rate as growth of the wild type in L broth, Figure 
8A.  Growth in minimal medium, T medium, is considerably different than wild type, 
Figure 8B.  The mutant undergoes a defect in growth at about 2 hours of growth in the 
incubator.  The growth curve done for the E. coli donor biotin auxotroph also showed a 
dip in growth at about 5 hours of growth.   
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Figure 8:  ∆bioA Growth Curves 
 
A: The ∆bioA mutant grows similarly to wild type in L broth.  Time points were taken 
every hour for 12 hours and then again at 24 hours. 
 
B:  The ∆bioA mutants exhibit a death and recovery phase in minimal medium. JW0757 
is the E. coli donor strain that has ∆bioA knocked out.  At approximately 2 hours, the 
∆bioA mutant S. flexneri begins to enter a death phase, and at approximately 5 hours the 
∆bioA E. coli exhibits a growth defect.  They both began to grow again, possibly picking 
up a suppressor mutation.   
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A: L broth growth curves 
 
B: Minimal medium growth curves, with and without supplementation of 100 µM biotin.  
Shown in green is the E. coli donor strain, in red is S. flexneri wild type 2457T, and in 
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Plaque Assays 
Plaque assays of Henle cell monolayers were done with the ∆lysA mutant.  The 
monolayers were stained and examined 48 and 72 hours post-infection (Figure 9A).  The 
wild type was used as a control for plaque number and size, although the wild type assay 
is only shown at the 48 hour time point. The monolayers infected by the wild type were 
completely destroyed by 72 hours.  The ∆lysA mutant formed plaques more slowly than 
wild type with no plaques visible after 48 hours.  At 72 hours post-infection, the 
monolayers showed the formation of fuzzy plaques indicating incomplete lysis of the 
epithelial cells by the ∆lysA mutant.  Since the number of plaques was equivalent to the 
wild type this would indicate that the ∆lysA mutants are able to attach and invade the 
epithelial cells, but the mutants may not be replicate or spread intracellularly as well as 
wild type.   
Plaque assays of Henle cell monolayers were also done with the ∆bioA mutant 






 cfu/ml of S. 
flexneri 2457T or ∆bioA mutant.  The plaque assays were done in medium both with and 
without 100uM biotin supplementation.  The infected monolayers were then incubated at 
37C/5%CO2 for 48 and 72 hours.  The monolayers were then stained and examined 48 
and 72 hours post-infection.  It was found that the amount of plaque formation was 
slightly lower in ∆bioA, although numerous plaques were formed after 48 hours.  The 
plaques formed were clear, indicating complete lysis, unlike with the lysA deletion 
mutant.  At 72 hours post-infection the monolayers displayed much larger plaques, 
 39 
although the wild type S. flexneri had completely destroyed the monolayer by 72 hours.   
There was no noticeable difference between the size and number of plaques formed when 
the infected monolayers were incubated with medium containing biotin supplementation 
compared to the monolayers with medium containing no biotin.  This was observed for 
both ∆bioA and the wild type S. flexneri.   
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Figure 9:  Plaque Assay Results.   
 
A: The S. flexneri ∆lysA did not plaque as efficiently as wild type S. flexneri 2457T. A. 
The ∆lysA infected monolayer 48 hours post-infection.  B. The ∆lysA infected monolayer 
72 hours post infection, showing “fuzzy” plaques.  C. The WT 2457T infected monolayer 
48 hours post-infection, showing clear, completely lysed plaques.   
 
 
B: The ∆bioA defective S. flexneri did not plaque as efficiently as wild type S. flexneri 
2457T. A. The ∆bioA infected monolayer 48 hours post-infection.  B. The ∆bioA infected 
monolayer 72 hours post-infection.  C. WT 2457T infected monolayer 48 hours post-
infection, showing clear, completely lysed plaques.    
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Invasion and Attachment Assays 
To examine the cause of the differences in plaquing ability, invasion and 
attachment assays were also performed on the ∆lysA and ∆bioA mutants. In the 
attachment assays, subconfluent Henle cells were examined for the presence of attached 
bacteria.  The number of individual bacteria attached was counted for 100 Henle cells in 
triplicate.  The ∆lysA mutant formed clumps of bacteria in both invasion and attachment 
assays, with clumps of up to 23 bacteria attached to Henle cells in the attachment assay.  
The wild type did not exhibit this phenotype in the attachment assay; individual bacteria 
were found to be attached to the Henle cells.   
In the invasion assay, 300 subconfluent Henle cells were examined for the 
presence or absence of intracellular bacteria.  A cell was considered to have been invaded 
if three or more bacteria were present.  The ∆lysA mutant invaded the Henle cells at a 
higher rate than the wild type, 55% of epithelial cells counted were invaded by ∆lysA 
compared to 33% by wild type.  The clumping of the ∆lysA mutant was also visible in the 
invasion assay, and the clumps were even larger than in the attachment assay, causing the 
results to be skewed.  The invasion assay requires that three or more bacteria have 
invaded a Henle cell for that Henle cell to be considered invaded.  The clumping 
phenotype of the biotin auxotroph conferred an advantage in that assay.  The wild type 
was more likely than the mutant to have only one or two bacteria invading a Henle cell 
than the ∆bioA mutant.  The clumping behavior was also visible in vitro in minimal 
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medium and L broth.  There was more settling of bacteria in the bottom test tubes 
containing the ∆lysA mutant compared to wild type S. flexneri.   
Invasion and attachment assays were also performed on Henle cell monolayers 
using the ∆bioA mutant and the 2457T wild type.  The ∆bioA mutant were able to attach 
at a higher rate than the wild type S. flexneri, the wild type averages 0.6 bacteria per 
epithelial cell while the ∆bioA averaged 1.1.  The invasion rates were much more similar; 
the ∆bioA mutant invaded 34% of the epithelial cells while the wild type invaded 28%.  
Biotin was present in the Henle medium so there were no virulence assays done of the 
∆bioA mutant grown without biotin supplementation.   
Plasmid Complementation 
 Once it was confirmed that the ∆lysA mutant was carrying the plasmid, through 
plasmid extraction and PCR, a growth curve was done using T medium, with and without 
supplementation of 300µM lysine.   The growth curve of the complemented ∆lysA mutant 
compared to the wild type 2457T and the uncomplemented ∆lysA is shown in Figure 10.  
The plaque assay results are shown in Figure 11.   
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Figure 10:  The growth curve of S. flexneri ∆lysA/pWKS30:lysA in T media, with and 
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Figure 11:   Plaque assay comparing the plamid complemented ∆lysA mutant to the wild 
type and the ∆lysA mutant.  The Henle cell monolayers were stained at 48 hours post 
infection.  A is the wild type 2457T, B is the ∆lysA mutant, and C is the plasmid 






The auxotrophic strains grew similarly to wild type in L broth, and both strains 
did not grow as well as wild type in minimal medium.  However, when the minimal 
medium was supplemented with either biotin or lysine, wild type growth rates were still 
not achieved by either auxotrophic strain.  This was unexpected since the deficiency in 
these strains should be solely in lysine or biotin biosynthesis.  The effect was more 
pronounced in the biotin auxotroph, where the addition of biotin had no noticeable effect 
of counteracting the growth defect observed when there was no supplementation.  The 
lysine auxotroph supplemented with lysine did show some improvement in growth over 
the auxotroph that was grown unsupplemented, but the growth was not at the level the 
wild type displayed. This occurrence could be given further attention in additional 
experiments.  It is possible that the levels of supplementation recommended for E. coli 
auxotrophs may not be sufficient in supplying S. flexneri with the nutrients it needs for a 
wild type growth rate.   
 The growth curve for S. flexneri missing the bioA gene showed a decrease in 
growth and subsequent recovery that was also exhibited by the E. coli ∆bioA strain used 
as a donor for the transduction.  This growth pattern was also found in a B. subtilis biotin 
auxotroph, although it was able to regain wild-type growth through supplementation with 
biotin (Sasaki, 2004).  The dip in growth was found to occur after the auxotroph had 
already begun to grow in the minimal medium.  One possible explanation for this 
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behavior is that a toxic intermediate is being produced and the mutants could be picking 
up a suppressor to allow for growth.   
The lysA deletion mutant was unable to produce clear, completely lysed plaques 
when it was compared to the plaquing ability of wild type S. flexneri 2457T.  The process 
that the mutation is affecting remains unresolved.  The attachment assay did not show a 
significant decrease in the ability of the mutant to attach to the surface of a Henle cell, 
and the invasion assay showed a higher rate of invasion than wild type.  Since the defect 
is not in attachment or invasion of epithelial cells, but is still causing turbid plaques, it is 
a possibility that the inability to synthesize lysine prevents the mutant from growing 
intracellularly or invading neighboring epithelial cells at the wild type rate.  The “fuzzy” 
phenotype of the plaques formed by the lysA deletion mutant may be an indicator of the 
inability of the mutant to lyse the infected epithelial cells.  If the ∆lysA mutant was 
unable to utilize lysine inside the epithelial cell, this may point to the concentration of 
lysine in the cytoplasm being too low to support bacterial growth.  The lysine that was 
present may be associated with its tRNA and unable to be utilized by the S. flexneri.  In 
order to make conclusions, future work will need to be carried out to examine the 
intercellular spread of this mutant.  Future work can also be done in examining additional 
genes in the lysine operon.   
         It was expected that the deletion mutants would not be able to plaque as efficiently, 
if at all, without supplemented nutrients.  The upregulation of these genes while S. 
flexneri is growing intracellularly indicates that they may be critical for intracellular 
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survival, replication, or growth or that these genes may just be required for optimal 
growth.  The defect in plaquing was not seen as dramatically in the bioA deletion mutant 
as in the lysA deletion mutant.  Wild type plaquing was also not seen when the 
auxotrophs were supplemented with biotin and lysine.  While it was expected that these 
genes would be necessary for intracellular growth because they have been found to 
upregulated, it is interesting to note that adding biotin and lysine to tissue culture media 
cannot bring back wild type plaque formation.  This holds some implications for 
proposed amino acid pools in eukaryotic cells.  If the pools of free amino acids in the 
cytosol are very small, the cytosolic environment would be more difficult for intracellular 
growth than previously thought.  Further research would aim to elucidate the 
concentrations of amino acids and vitamin cofactors in the epithelial cells that could 
potentially be utilized by the S. flexneri.   
 The presence of turbid plaques in a plaque assay indicates incomplete lysis of the 
epithelial cells.  This would indicate that not all of the infected epithelial cells are being 
lysed and releasing more S. flexneri into the extracellular environment.  The inability of 
some of the lysA deficient bacteria to lyse the epithelial cells could be caused by 
interruptions in the normal life cycle of S. flexneri at various stages.  Alternatively, the 
incomplete lysis could be due to the ∆lysA mutation causing a delayed lethality in the 
mutants.  The auxotrophic intracellular bacteria may be dying because of complications 
of the lysine deficiency prior to inducing lysis, resulting in the characteristic fuzzy 
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plaques.  This could also account for the lower and slower frequency of plaquing in the 
∆lysA mutant.   
 The observation of finding fewer ∆bioA plaques could be caused by a possible 
defect interfering with the intracellular life cycle of the biotin auxotroph.  Since the 
plaques are clear and completely lysed, the issue may be in the replication of the S. 
flexneri rather than in the lysing of the epithelial cells.  The defect could also be affecting 
intracellular spread, since the invasion and attachment assays were similar to wild type.  
S. flexneri undergoes many changes in order to spread between epithelial cells after 
initially replicating inside the infected epithelial cells.  Processes that could account for a 
defect in intracellular spread would include aberrant actin polymerization and problems 
with inducing pseudo-pinocytosis or vacuole lysis.   
 Complementation of the bioA and lysA deletion mutants via plasmids carrying 
bioA and lysA is a future direction of this work.  Complementation of the deleted genes is 
vital to ensuring that the target genes are responsible for the phenotypes of the mutants.  
It is expected that once the bioA auxotroph is complemented with the plasmid that it will 
exhibit wild type growth and virulence.  
 ∆lysA has been successfully complemented with a plasmid carrying the lysA 
gene.  ∆lysA carrying the plasmid grew at a rate comparable to wild type in minimal 
media, independent of supplementation with lysine.  Plaque assays using the plasmid 
complemented ∆lysA showed clearly lysed plaques in the Henle monolayers.  Since the 
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plasmid carrying lysA was able to restore wild type behavior to the auxotroph, this lends 
support to lysA being required for virulence.   
  The ∆lysA clumping phenotype could possibly be due to a defect in the bacterial 
cell walls.  The last precursor for the synthesis of lysine, meso-DAP, is also a constituent 
of peptidoglycan.  Conceivably, the build-up of meso-DAP could be affecting the cell 
membranes, causing the ∆lysA bacteria to clump together.  In order to test, this future 
research could involve engineering deletion mutants in lysine synthesis genes that 
precede the production of meso-DAP.  If those mutants clumped the defect may be 
caused by the loss of lysine biosynthesis rather than a build-up of meso-DAP.   
In order to determine if the build-up of meso-DAP or the absence of lysine is 
causing the clumping phenotype of the ∆lysA mutant, work can be done on deleting 
additional lysine biosynthesis genes and examining the consequences of those deletions.  
If it is the loss of lysine biosynthesis that causes the phenotype, deleting any gene in the 
pathway should result in the reduced pathogenicity in the virulence assays.  If the build-
up of meso-DAP causes the phenotype, deleting any genes prior to the synthesis of meso-





NaCl  5g 
Tryptone 10g 
Yeast extract 5g 
dH2O  1000ml 
 
Add all components to 1000ml dH2O.  Use stir bar and stir plate to homogenize the solution.  
Aliquot 300 ml into glass bottles and autoclave.  To make L agar, prior to autoclaving add 5 g of 
agar to 300ml L broth.   
 
T Medium 
NaCl  5.8g 
KCl  3.7g 
CaCl2  0.113g 
MgCl2-6H2O 0.1g 
NH4Cl  1.1g 
KH2PO4 0.272g 
Na2SO4  0.142g 
Tris  12.1g 
dH20  1000ml 
 
Dissolve all components in 1000ml dH2O.  While stirring pH the medium to 7.4 using highly 
concentrated HCl.  Aliquot 300 ml into glass bottles and autoclave.  Add 4.8 g agar to 100 ml T 
medium prior to autoclaving in order to make T agar.  After autoclaving add 0.4% and 2 µg/ml 
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